ESR2 and central nervous system cancer: Diverse reports have shown that an elevated expression of ERβ or its stimulation with selective agonists can inhibit the processes of malignancy in gliomas by promoting the deregulation of mechanisms of DNA repair in tumors, including the pathway of homologous recombination [98,99].